{"id":50144,"date":"2026-08-03T11:54:16","date_gmt":"2026-08-03T19:54:16","guid":{"rendered":"https:\/\/4dmedical.com\/us\/?p=50144"},"modified":"2026-08-03T11:54:18","modified_gmt":"2026-08-03T19:54:18","slug":"ai-lung-cancer-risk-assessment-functional-imaging","status":"publish","type":"post","link":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/","title":{"rendered":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">4DMedical announces a distribution agreement and strategic investment in RevealDx, adding the clinically validated RevealAI-Lung solution to its expanding cardiopulmonary imaging ecosystem. RevealAI-Lung uses artificial intelligence to characterize pulmonary nodules and generate a Malignancy Similarity Index (mSI\u2122), helping radiologists make more informed follow-up recommendations and supporting cancer diagnosis. The software has been validated in more than 1,500 patients and is MDR certified, FDA cleared, and TGA approved.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership brings together complementary technologies that address different aspects of lung disease evaluation. RevealAI-Lung provides AI-driven risk stratification of pulmonary nodules, while 4DMedical&#8217;s functional imaging portfolio, including CT:VQ\u2122, provides physiological information about how the lungs are functioning. According to 4DMedical, the combination of disease detection, AI-powered risk stratification, and functional imaging supports its vision of a connected ecosystem for cardiopulmonary care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The value lies in having access to technologies that can help identify potentially malignant lung nodules, support follow-up decisions, and provide additional functional information about lung health. By combining nodule characterization with advanced ventilation and perfusion imaging, the partnership expands the range of clinical information available to support patient evaluation and care decisions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The agreement also builds on 4DMedical&#8217;s recent acquisition of contextflow, whose chest CT platform already includes RevealAI-Lung and is operational at several clinical sites. This creates an opportunity to further integrate complementary imaging and AI technologies within a single respiratory care ecosystem.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership represents another step in 4DMedical&#8217;s strategy to assemble a comprehensive portfolio of respiratory imaging and artificial intelligence solutions. The addition of RevealAI-Lung enhances 4DMedical&#8217;s ability to offer clinicians tools spanning disease detection, risk stratification, and functional assessment, further strengthening the company&#8217;s long-term platform approach to respiratory and cardiopulmonary care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2026\/08\/RevealDx-4DMedical-Announcement.pdf\">Read the article.<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4DMedical has entered a distribution agreement and strategic investment partnership with RevealDx, bringing RevealAI-Lung into its expanding cardiopulmonary imaging ecosystem. RevealAI-Lung uses artificial intelligence to characterize pulmonary nodules and provide a Malignancy Similarity Index (mSI\u2122) that helps radiologists make more informed follow-up recommendations. Together with 4DMedical&#8217;s functional imaging technologies, the partnership strengthens a platform designed to combine disease detection, AI-powered risk stratification, and physiological assessment of lung function.<\/p>\n","protected":false},"author":5,"featured_media":50140,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[2],"tags":[76,66,71,72],"class_list":["post-50144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-copd","tag-healthcare-industry-trends","tag-pulmonology","tag-radiology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US<\/title>\n<meta name=\"description\" content=\"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US\" \/>\n<meta property=\"og:description\" content=\"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"4DMedical US\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T19:54:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-03T19:54:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/2026\/08\/RevealDX-and-4D-Partner-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Michelle Martin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michelle Martin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/\"},\"author\":{\"name\":\"Michelle Martin\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#\\\/schema\\\/person\\\/dac6f29cd556fa750bdea707a0899844\"},\"headline\":\"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership\",\"datePublished\":\"2026-08-03T19:54:16+00:00\",\"dateModified\":\"2026-08-03T19:54:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/\"},\"wordCount\":296,\"publisher\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/08\\\/RevealDX-and-4D-Partner-2.png\",\"keywords\":[\"COPD\",\"Healthcare Industry Trends\",\"Pulmonology\",\"Radiology\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/\",\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/\",\"name\":\"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/08\\\/RevealDX-and-4D-Partner-2.png\",\"datePublished\":\"2026-08-03T19:54:16+00:00\",\"dateModified\":\"2026-08-03T19:54:18+00:00\",\"description\":\"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/08\\\/RevealDX-and-4D-Partner-2.png\",\"contentUrl\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/08\\\/RevealDX-and-4D-Partner-2.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/2026\\\/08\\\/03\\\/ai-lung-cancer-risk-assessment-functional-imaging\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/\",\"name\":\"4DMedical US\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#organization\",\"name\":\"4DMedical US\",\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/09\\\/4D-logo-on-navy.png\",\"contentUrl\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/09\\\/4D-logo-on-navy.png\",\"width\":418,\"height\":83,\"caption\":\"4DMedical US\"},\"image\":{\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/#\\\/schema\\\/person\\\/dac6f29cd556fa750bdea707a0899844\",\"name\":\"Michelle Martin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g\",\"caption\":\"Michelle Martin\"},\"url\":\"https:\\\/\\\/4dmedical.com\\\/us\\\/blog\\\/author\\\/mmartin4dmedical-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US","description":"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/","og_locale":"en_US","og_type":"article","og_title":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US","og_description":"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.","og_url":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/","og_site_name":"4DMedical US","article_published_time":"2026-08-03T19:54:16+00:00","article_modified_time":"2026-08-03T19:54:18+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/2026\/08\/RevealDX-and-4D-Partner-2.png","type":"image\/png"}],"author":"Michelle Martin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Michelle Martin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#article","isPartOf":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/"},"author":{"name":"Michelle Martin","@id":"https:\/\/4dmedical.com\/us\/#\/schema\/person\/dac6f29cd556fa750bdea707a0899844"},"headline":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership","datePublished":"2026-08-03T19:54:16+00:00","dateModified":"2026-08-03T19:54:18+00:00","mainEntityOfPage":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/"},"wordCount":296,"publisher":{"@id":"https:\/\/4dmedical.com\/us\/#organization"},"image":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2026\/08\/RevealDX-and-4D-Partner-2.png","keywords":["COPD","Healthcare Industry Trends","Pulmonology","Radiology"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/","url":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/","name":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership - 4DMedical US","isPartOf":{"@id":"https:\/\/4dmedical.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#primaryimage"},"image":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2026\/08\/RevealDX-and-4D-Partner-2.png","datePublished":"2026-08-03T19:54:16+00:00","dateModified":"2026-08-03T19:54:18+00:00","description":"4DMedical and RevealDx have partnered to combine AI lung cancer risk assessment with advanced functional lung imaging, helping physicians make more informed diagnostic and follow-up decisions.","breadcrumb":{"@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#primaryimage","url":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2026\/08\/RevealDX-and-4D-Partner-2.png","contentUrl":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2026\/08\/RevealDX-and-4D-Partner-2.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/4dmedical.com\/us\/blog\/2026\/08\/03\/ai-lung-cancer-risk-assessment-functional-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/4dmedical.com\/us\/"},{"@type":"ListItem","position":2,"name":"AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership"}]},{"@type":"WebSite","@id":"https:\/\/4dmedical.com\/us\/#website","url":"https:\/\/4dmedical.com\/us\/","name":"4DMedical US","description":"","publisher":{"@id":"https:\/\/4dmedical.com\/us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/4dmedical.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/4dmedical.com\/us\/#organization","name":"4DMedical US","url":"https:\/\/4dmedical.com\/us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/4dmedical.com\/us\/#\/schema\/logo\/image\/","url":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2022\/09\/4D-logo-on-navy.png","contentUrl":"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2022\/09\/4D-logo-on-navy.png","width":418,"height":83,"caption":"4DMedical US"},"image":{"@id":"https:\/\/4dmedical.com\/us\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/4dmedical.com\/us\/#\/schema\/person\/dac6f29cd556fa750bdea707a0899844","name":"Michelle Martin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5f8f4ffe4d9ac18164566998f6d39caa95d4747465a8dac4072582d7c282399f?s=96&d=mm&r=g","caption":"Michelle Martin"},"url":"https:\/\/4dmedical.com\/us\/blog\/author\/mmartin4dmedical-com\/"}]}},"_links":{"self":[{"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/posts\/50144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/comments?post=50144"}],"version-history":[{"count":4,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/posts\/50144\/revisions"}],"predecessor-version":[{"id":50148,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/posts\/50144\/revisions\/50148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/media\/50140"}],"wp:attachment":[{"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/media?parent=50144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/categories?post=50144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/4dmedical.com\/us\/wp-json\/wp\/v2\/tags?post=50144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}